To stay ahead of risks, manufacturers must move beyond basic due diligence and embrace continuous supplier monitoring and education.
In today’s interconnected world, supply chain vulnerabilities can cripple businesses in an instant. From tech and biotech to pharma and agriculture, manufacturers across industries are left grappling with escalating risks in their supply chains. From regulatory pressures to ethical considerations and public health crises, companies must proactively manage vulnerabilities to maintain operational resilience. Coupled with insights from LRN’s 2025 Ethics & Compliance Program Effectiveness Report, let’s explore the multifaceted approach businesses should adopt to mitigate risks and drive supply chain excellence.
Recent outbreaks of the bird flu across the U.S. have led to supply shortages, disruptions, and higher costs in the food industry. It is a stark reminder of how biological threats can ripple across supply chains. At the same time, evolving regulations, such as the UK’s Economic Crime and Corporate Transparency Act (ECCTA) and updates from the U.S. Department of Justice (DOJ) on corporate compliance expectations, are reshaping the landscape for due diligence and risk mitigation. Layered onto this, the growing role of AI in supply chain management raises ethical concerns that must be addressed alongside efficiency gains.
As businesses navigate unprecedented and complex dynamics, an integrated approach—leveraging continuous third-party monitoring, regulatory alignment, and ethical AI practices—will ensure stability, compliance, and long-term success. Companies that lag behind in adopting these practices risk operational breakdowns and regulatory reviews.
Regulatory scrutiny of supply chains is intensifying across all sectors. The UK’s ECCTA has introduced new fraud prevention measures aimed at increasing transparency, making it imperative for businesses operating in the UK to reassess their due diligence processes. ECCTA places significant responsibility on corporate leadership to cultivate a culture of compliance. In practice, this means that board members and senior management will be required to oversee fraud prevention programs, conduct regular risk assessments, and ensure that anti-fraud measures are adequately resourced.
Similarly, the DOJ’s latest guidance on evaluating corporate compliance programs underscores the need for ongoing monitoring rather than a static, one-time vetting process. The shift to dynamic due diligence monitoring is vital for identifying emerging risks and ensuring suppliers remain aligned with a company’s standards over time.
Other compliance frameworks, such as the Foreign Corrupt Practices Act (FCPA), primarily focus on preventing companies from engaging in bribery and corruption to influence foreign officials. At the same time, food and agriculture manufacturers must adhere to stringent safety regulations, such as those outlined by the FDA, USDA, and international food safety bodies, especially in the wake of biological threats like avian flu.
Pharma and biotech manufacturers face additional layers of oversight from agencies like the FDA and EMA, particularly regarding Good Manufacturing Practices (GMP) and supply chain integrity for active pharmaceutical ingredients (APIs). Any lapse in regulatory adherence can lead to costly recalls, reputational damage, and legal consequences.
To stay ahead of risks, manufacturers must move beyond basic due diligence and embrace continuous supplier monitoring and education. One of the most impactful ways to mitigate third-party risks is through comprehensive training programs that ensure suppliers understand and adhere to a company’s compliance requirements. This involves real-time oversight, regular audits, and data-driven risk assessments to ensure compliance and ethical standards are upheld over time.
By equipping third-party suppliers with the knowledge and tools they need to uphold standards, businesses can create a culture of accountability and reduce the likelihood of non-compliance.
AI-powered monitoring systems are revolutionizing how food production companies track supplier compliance, pharma companies detect anomalies, and biotech manufacturers mitigate risks. However, this transformation brings significant accountability risks, requiring these technologies to be implemented responsibly. AI should enhance transparency rather than introduce new ethical concerns related to transparency, bias, and data privacy. AI systems are only as reliable as the data they learn from, and without proper oversight, they can reinforce existing biases or create new vulnerabilities.
For example, blockchain technology is increasingly being used to track the source of materials, verify suppliers, and manage risk in real time. By maintaining immutable records of supplier transactions, businesses can have more transparency and the ability to trace issues back to their source.
Many companies have successfully implemented robust due diligence and monitoring practices, setting benchmarks for others to follow. Encouraging third-party suppliers to engage in tailored compliance training furthers unified alignment between manufacturers and their partners. Requiring suppliers to certify their understanding and adherence to ethical standards ensures accountability and provides manufacturers with mechanisms to monitor compliance throughout their supply chains.
In today’s increasingly complex and interconnected world, supply chain due diligence and continuous monitoring are essential for compliance, long-term resilience, and competitiveness. From the evolving regulatory landscape to the risks posed by public health crises, recent challenges have stressed the need for businesses to be proactive rather than reactive in managing third-party relationships, from the evolving regulatory landscape to the risks posed by public health crises.
By integrating comprehensive training programs, embracing AI-driven risk assessments, and enforcing stringent supplier audits, companies can build resilient, ethical, transparent, and future-ready supply chains. The stakes are high, but with proactive strategies, manufacturers can navigate uncertainty and maintain operational excellence in a rapidly shifting global landscape.